Provided by Tiger Trade Technology Pte. Ltd.

Actinium Pharmaceuticals

1.03
-0.0200-1.90%
Post-market: 1.030.00000.00%17:49 EDT
Volume:182.01K
Turnover:186.65K
Market Cap:32.13M
PE:-0.93
High:1.05
Open:1.03
Low:1.01
Close:1.05
52wk High:1.98
52wk Low:1.01
Shares:31.20M
Float Shares:31.04M
Volume Ratio:1.11
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1090
EPS(LYR):-1.2718
ROE:-133.09%
ROA:-33.76%
PB:2.33
PE(LYR):-0.81

Loading ...

Nov 02, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Major Issues Report

8-K - Current report
Feb 06, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2022

Major Issues Report

8-K - Current report
Dec 09, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 29, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 13, 2022

Major Issues Report

8-K - Current report
Mar 25, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Sep 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 03, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities